Bone Pain Score Validation Initiative

Prospective Epidemiology Study to Validate the BOMET-QoL-10 in Patients With Bone Metastasis in Germany

Translation and validation of the BOMET-QoL-10 questionnaire in Germany and assessment of its validity and responsiveness.

Aim of this study is to translate the questionnaire and to examine the psychometric properties of BOMET-QoL-10 in a German population. Correlations with the EORTC QLQ-C30/BM22 at the time of enrolment and throughout the study aim to verify that the BOMET-QoL-10 is reliable, valid and able to detect stabilization or changes in quality of life.

Inclusion Criteria:

• Male or female adults patients (≥ 18 years)
• Diagnosed cancer of the breast, kidney, lung or prostate
• Bone metastases
• Estimated life expectancy of at least 6 months
• Fluent German speaking, reading and writing
• Informed written consent

Exclusion Criteria:

• Patients without bone metastases
• Participation in another study involving questionnaires
• Patients not able to comply with the assessments specified in the protocol